Fosfomycin Disodium
CAS No. 26016-99-9
Fosfomycin Disodium ( —— )
产品货号. M21403 CAS No. 26016-99-9
磷霉素是一种杀菌、低分子量、广谱抗生素,通过不可逆地抑制细胞壁合成的早期阶段,对多种细菌(包括多重耐药革兰氏阴性菌)具有假定活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | ¥332 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Fosfomycin Disodium
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述磷霉素是一种杀菌、低分子量、广谱抗生素,通过不可逆地抑制细胞壁合成的早期阶段,对多种细菌(包括多重耐药革兰氏阴性菌)具有假定活性。
-
产品描述Fosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.
-
体外实验Fosfomycin sodium is an epoxy antibacterial agent. Compared with other antibacterial agents, it acts by inhibiting the early process of cell wall synthesis.Fosfomycin sodium has bactericidal activity against a variety of gram-negative and gram-positive pathogens, including broad-spectrum production β-Bacteria of lactamase and carbapenemase, and against S. aureus strains with an inhibition rate of 90%.Fosfomycin sodium displays extensive tissue penetration, can be used to research of infections of the CNS, soft tissues, bone, lungs, and abscesses.
-
体内实验Fosfomycin sodium (80 mg/kg; i.v.-i.v. or i.v.-p.o.) displays the protective effect on the nephrotoxicity of double beckacin, and is not affected by different administration routes.Pharmacokinetic of Fosfomycin sodium in Rats. Animal Model:Fischer 344 rats Dosage:320 mg/kg Administration:Intramuscular injection, 5 schedules: 1 h, 0.5 h earlier than dibekacin, concomitantly, 0.5 h later and 1 h later; 11 days Result:Reduced polyuria, proteinuria, enzymes and cytosine caused by dibecacin (40 mg/kg), followed by the previous treatment.Animal Model:Dehydrated Wistar rat with acute renal failure (8-week-old)Dosage:120 mg/kg Administration:Intravenous injection; once Result:Recovered the exclusion rate of rats basically to normal, and improved the nephrotoxicity parameters.Protects proximal tubular lysosomes from aminoglycosides by inhibiting myeloid formation and protecting the integrity of lysosomal membrane of rats treated with double bekacin.
-
同义词——
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症Urinary Tract InfectionAsymptomatic Bacteriuria
化学信息
-
CAS Number26016-99-9
-
分子量182.02
-
分子式C3H5Na2O4P
-
纯度>98% (HPLC)
-
溶解度H2O:36 mg/mL (197.78 mM)
-
SMILESC[C@@H]1O[C@@H]1P([O-])([O-])=O.[Na+].[Na+]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Dijkmans AC et al. Fosfomycin: Pharmacological Clinical and Future Perspectives. Antibiotics (Basel). 2017 Oct 31;6(4). pii: E24.
产品手册
关联产品
-
Nilofabicin
Nilofabicin 是一种有效的烯酰(酰基载体蛋白)还原酶下降(FabI)抑制剂,可用于治疗复杂急性疾病的研究。
-
Ridinilazole
瑞地尼拉唑是一种新型窄谱不可吸收抗生素。
-
Tigemonam
Tigemonam 是一种单菌霉素,可以抵抗革兰氏阴性需氧细菌病原体。
021-51111890
购物车()
sales@molnova.cn

